QLDTI: A Novel Reinforcement Learning-based Prediction Model for Drug-Target Interaction

IF 2.4 3区 生物学 Q3 BIOCHEMICAL RESEARCH METHODS Current Bioinformatics Pub Date : 2023-10-16 DOI:10.2174/0115748936264731230928112936
Jie Gao, Qiming Fu, Jiacheng Sun, Yunzhe Wang, Youbing Xia, You Lu, Hongjie Wu, Jianping Chen
{"title":"QLDTI: A Novel Reinforcement Learning-based Prediction Model for Drug-Target Interaction","authors":"Jie Gao, Qiming Fu, Jiacheng Sun, Yunzhe Wang, Youbing Xia, You Lu, Hongjie Wu, Jianping Chen","doi":"10.2174/0115748936264731230928112936","DOIUrl":null,"url":null,"abstract":"Background: Predicting drug-target interaction (DTI) plays a crucial role in drug research and development. More and more researchers pay attention to the problem of developing more powerful prediction methods. Traditional DTI prediction methods are basically realized by biochemical experiments, which are time-consuming, risky, and costly. Nowadays, DTI prediction is often solved by using a single information source and a single model, or by combining some models, but the prediction results are still not accurate enough. Objective: The study aimed to utilize existing data and machine learning models to integrate heterogeneous data sources and different models, further improving the accuracy of DTI prediction. Methods: This paper has proposed a novel prediction method based on reinforcement learning, called QLDTI (predicting drug-target interaction based on Q-learning), which can be mainly divided into two parts: data fusion and model fusion. Firstly, it fuses the drug and target similarity matrices calculated by different calculation methods through Q-learning. Secondly, the new similarity matrix is inputted into five models, NRLMF, CMF, BLM-NII, NetLapRLS, and WNN-GIP, for further training. Then, all sub-model weights are continuously optimized again by Q-learning, which can be used to linearly weight all sub-model prediction results to output the final prediction result. Results: QLDTI achieved AUC accuracy of 99.04%, 99.12%, 98.28%, and 98.35% on E, NR, IC, and GPCR datasets, respectively. Compared to the existing five models NRLMF, CMF, BLM-NII, NetLapRLS, and WNN-GIP, the QLDTI method has achieved better results on four benchmark datasets of E, NR, IC, and GPCR. Conclusion: Data fusion and model fusion have been proven effective for DTI prediction, further improving the prediction accuracy of DTI.","PeriodicalId":10801,"journal":{"name":"Current Bioinformatics","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748936264731230928112936","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Predicting drug-target interaction (DTI) plays a crucial role in drug research and development. More and more researchers pay attention to the problem of developing more powerful prediction methods. Traditional DTI prediction methods are basically realized by biochemical experiments, which are time-consuming, risky, and costly. Nowadays, DTI prediction is often solved by using a single information source and a single model, or by combining some models, but the prediction results are still not accurate enough. Objective: The study aimed to utilize existing data and machine learning models to integrate heterogeneous data sources and different models, further improving the accuracy of DTI prediction. Methods: This paper has proposed a novel prediction method based on reinforcement learning, called QLDTI (predicting drug-target interaction based on Q-learning), which can be mainly divided into two parts: data fusion and model fusion. Firstly, it fuses the drug and target similarity matrices calculated by different calculation methods through Q-learning. Secondly, the new similarity matrix is inputted into five models, NRLMF, CMF, BLM-NII, NetLapRLS, and WNN-GIP, for further training. Then, all sub-model weights are continuously optimized again by Q-learning, which can be used to linearly weight all sub-model prediction results to output the final prediction result. Results: QLDTI achieved AUC accuracy of 99.04%, 99.12%, 98.28%, and 98.35% on E, NR, IC, and GPCR datasets, respectively. Compared to the existing five models NRLMF, CMF, BLM-NII, NetLapRLS, and WNN-GIP, the QLDTI method has achieved better results on four benchmark datasets of E, NR, IC, and GPCR. Conclusion: Data fusion and model fusion have been proven effective for DTI prediction, further improving the prediction accuracy of DTI.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
QLDTI:一种基于强化学习的药物-靶标相互作用预测模型
背景:药物-靶标相互作用预测(DTI)在药物研究和开发中起着至关重要的作用。如何开发更强大的预测方法已成为越来越多研究者关注的问题。传统的DTI预测方法基本通过生化实验实现,耗时长、风险大、成本高。目前,DTI预测通常采用单一信息源和单一模型来解决,或者将多个模型组合起来解决,但预测结果仍然不够准确。目的:利用现有数据和机器学习模型,整合异构数据源和不同模型,进一步提高DTI预测的准确性。方法:本文提出了一种基于强化学习的新型预测方法,称为QLDTI(基于Q-learning的药物-靶标相互作用预测),该方法主要分为数据融合和模型融合两部分。首先,通过Q-learning将不同计算方法计算出的药物和目标相似度矩阵进行融合。其次,将新的相似矩阵输入到NRLMF、CMF、BLM-NII、NetLapRLS和WNN-GIP五个模型中进行进一步训练。然后,通过Q-learning再次连续优化所有子模型的权重,利用Q-learning对所有子模型的预测结果进行线性加权,输出最终的预测结果。结果:QLDTI在E、NR、IC和GPCR数据集上的AUC准确率分别为99.04%、99.12%、98.28%和98.35%。与现有的NRLMF、CMF、BLM-NII、NetLapRLS和WNN-GIP 5种模型相比,QLDTI方法在E、NR、IC和GPCR 4个基准数据集上取得了更好的结果。结论:数据融合和模型融合对DTI预测是有效的,进一步提高了DTI的预测精度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Bioinformatics
Current Bioinformatics 生物-生化研究方法
CiteScore
6.60
自引率
2.50%
发文量
77
审稿时长
>12 weeks
期刊介绍: Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science. The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.
期刊最新文献
Mining Transcriptional Data for Precision Medicine: Bioinformatics Insights into Inflammatory Bowel Disease Prediction of miRNA-disease Associations by Deep Matrix Decomposition Method based on Fused Similarity Information TCM@MPXV: A Resource for Treating Monkeypox Patients in Traditional Chinese Medicine Identifying Key Clinical Indicators Associated with the Risk of Death in Hospitalized COVID-19 Patients A Parallel Implementation for Large-Scale TSR-based 3D Structural Comparisons of Protein and Amino Acid
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1